000 02354nam  2200445zi 4500
0019.935843
003CaOODSP
00520240711133500
006m     o  d f      
007cr cn|||||||||
008240322e20240326oncabdo o    f00| 0 eng d
020 |a9780660709598
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH14-593/2024E-PDF
24500|aYouth marketing product validation : |bquantitative and qualitative study : report / |csubmitted to department of Health Canada.
264 1|aOttawa, Ontario : |bHealth Canada = Santé Canada, |c2024.
264 4|c©2024
300 |a1 online resource (164 pages) : |billustrations, maps, graphs, photographs + |e1 summary (23 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aCover title.
500 |a"Prepared by Leger."
500 |a"Contract number: CW2329161."
500 |a"POR 042-23."
500 |a"Delivery date: March 26 2024."
500 |aIssued also in French under title: Validation de produits de marketing chez les jeunes : étude quantitative et qualitative : rapport.
520 |a"This report details the findings from two waves of research on personal protective measures, which include a survey and focus groups, as well as from a third wave of research focusing on Health Canada's vaping module, conducted through focus groups"--Executive summary, page 5.
650 0|aAdvertising and youth|zCanada.
650 0|aVaping|xHealth aspects|zCanada|xPublic opinion.
650 0|aPublic health|zCanada|xPublic opinion.
7101 |aCanada. |bHealth Canada, |eissuing body.
7102 |aLéger Marketing, |econsultant.
77508|tValidation de produits de marketing chez les jeunes : |w(CaOODSP)9.935845
85640|qPDF|s6.07 MB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-593-2024-eng.pdf|zReport
85640|qPDF|s1.39 MB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/H14-593-2024-1-eng.pdf|zSummary
8564 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2024/042-23-e/042-23-report.html|zReport
8564 |qHTML|sN/A|uhttps://epe.bac-lac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2024/042-23-e/summary/042-23-summary.html|zSummary